We believe that the immunotherapy of melanoma represents a fundamental approach in the treatment of this disease. In this regard the monoclonal antibodies, because of their high specificity, their demonstrated lack of toxicity after repeated injection and the possibility of their use both as direct cytotoxic factors and carriers of other molecules, constitute one of the most intriguing prospectives of therapy of this threatening cancer.
|Number of pages||4|
|Journal||Nuclear Medicine and Biology|
|Publication status||Published - 1989|
ASJC Scopus subject areas
- Cancer Research
- Molecular Medicine
- Radiology Nuclear Medicine and imaging